1. CTNI-24. A PHASE 1/2 STUDY OF AVAPRITINIB IN PEDIATRIC PATIENTS WITH SOLID TUMORS DEPENDENT ON KIT OR PDGFRA SIGNALING. (12th November 2021) Authors: Chi, Susan; Hsieh, Antony; Foley, Megan; Shi, Hongliang; Swamy, Preethi; Rodstrom, Jill; Rudoltz, Marc Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EPCT-05. A PHASE 1/2 STUDY OF AVAPRITINIB FOR KIT- OR PDGFRA-MUTANT PEDIATRIC RELAPSED/REFRACTORY SOLID TUMORS. (1st June 2021) Authors: Chi, Susan; Hsieh, Antony; Foley, Megan; Shi, Hongliang; Swamy, Preethi; Rodstrom, Jill; Rudoltz, Marc Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EPCT-09. ROVER: A phase 1/2 study of avapritinib in pediatric patients with solid tumors dependent on KIT or PDGFRA signaling. (3rd June 2022) Authors: Chi, Susan; Hsieh, Antony; Foley, Megan; Shi, Hongliang; Swamy, Preethi; Rodstrom, Jill; Rudoltz, Marc Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High Concordance Observed Between Local and Central INI1 Immunohistochemistry Results Obtained From Clinical Studies EZH-102 and EZH-202. (21st September 2018) Authors: Hawes, Debra; Daigle, Scott; Alvarez, Rita; Corder, Ruth; Rodstrom, Jill; Blakemore, Stephen; Roche, Maria; Judkins, Alexander Journal: American journal of clinical pathology Issue: Volume 150(2018)Supplement 1 Page Start: S133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗